{"schema_version":"secwatch.filing_event.v1","accession":"0001625297-26-000012","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2026-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.674324+00:00","generated_at":"2026-05-15T12:36:40.820850+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"confidence":"high","headline":"Indivior prices upsized $450M convertible notes at 0.625% due 2031","bullets":["Principal amount $450M (upsized from $400M); 0.625% interest, matures March 15, 2031.","Net proceeds ~$437.7M (~$486.4M if initial purchasers' option fully exercised).","~$239M of proceeds plus $102M cash used to repay term loan and revolver.","Concurrent $75M repurchase of ~2.4M shares from note purchasers at market price.","Initial conversion price ~$41.66/share, a 35% premium over March 12 closing price."],"urls":{"canonical":"https://secwatch.observer/filing/0001625297-26-000012","json":"https://secwatch.observer/filing/0001625297-26-000012.json","markdown":"https://secwatch.observer/filing/0001625297-26-000012.md","text":"https://secwatch.observer/filing/0001625297-26-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000162529726000012/0001625297-26-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000162529726000012/indv-20260312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T12:36:40.820850+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}